Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07512154 · ClinicalTrials.gov registry record · NA
Precision Radiotherapy Enabled by Molecular MRI
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07512154 is a NA study that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 20 participants.
The verdict
NCT07512154, a NA study, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a research study to determine if a novel molecular magnetic resonance imaging (MRI) technique, called amide proton transfer (APT) imaging, is useful in identifying the most aggressive areas of tumor needed for radiotherapy of brain tumors.
Interventions
- RADIATION Standard radiotherapy
- RADIATION Amide proton transfer radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-04-29 |
| Est. Completion | 2032-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07512154
The ClinicalTrials.gov registry entry for NCT07512154 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard radiotherapy is the first listed.
NCT07512154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07512154 about?
NCT07512154 is a clinical study titled "Precision Radiotherapy Enabled by Molecular MRI". This is a research study to determine if a novel molecular magnetic resonance imaging (MRI) technique, called amide proton transfer (APT) imaging, is useful in identifying the most aggressive areas of tumor needed for radiotherapy of brain tumors.
What is the current status of trial NCT07512154?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-04-29. Estimated completion is 2032-05.
What interventions are being tested in trial NCT07512154?
The interventions under investigation include: Standard radiotherapy (RADIATION), Amide proton transfer radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT07512154?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.